A study in head and neck cancer cells showed that silencing SIRT1 expression can inhibit epithelial-mesenchymal transition and decrease ferroptosis, while SIRT1 agonists can promote ferroptosis (68). This evidence concerns the gene SIRT1 and head and neck cancer.